a-Ergocryptine

CAS: 511-09-1

Ref. 3D-FE22782

Información del producto

• Nombre: a-Ergocryptine
• Sinónimos: 12'-Hydroxy-2'-(1-methylethyl)-5'-a-(2-methylpropyl)ergotaman-3',6',18-trione, (2'Xi,12'Xi)-12'-Hydroxy-5'-(2-Methylpropyl)-3',6',18-Trioxo-2'-(Propan-2-Yl)Ergotaman, (5'Alpha)-12'-Hydroxy-5'-(2-Methylpropyl)-3',6',18-Trioxo-2'-(Propan-2-Yl)Ergotaman, (5′α)-12′-Hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)ergotaman-3′,6′,18-trione, 12'-Hydroxy-5'-(2-Methylpropyl)-3',6',18-Trioxo-2'-(Propan-2-Yl)Ergotaman, 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3′,6′,18-trione deriv., ALPHA-Ergocryptine, Ergocryptine, Ergokryptine, Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-(2-methylpropyl)-, (5′α)-, Indolo[4,3-fg]quinoline, ergotaman-3′,6′,18-trione deriv., NSC 169479, NSC 407319, α-Ergokryptine

Descripción

Ergocryptine is a dopamine receptor agonist with an active conformation that binds to the D2 and D3 receptors. It has been shown to be effective in treating some symptoms of Parkinson's disease, such as tremors and rigidity. Ergocryptine has also been shown to have a positive effect on the ovaries by inhibiting their function. This drug does not react chemically with zearalenone or guanylate, but it does inhibit cyclase activity, which leads to enhancement of the ergometrine reaction products.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 575.7 g/mol
• Fórmula: C₃₂H₄₁N₅O₅
• Pureza: Min. 95%
• InChI: InChI=1S/C32H41N5O5/c1-17(2)12-25-29(39)36-11-7-10-26(36)32(41)37(25)30(40)31(42-32,18(3)4)34-28(38)20-13-22-21-8-6-9-23-27(21)19(15-33-23)14-24(22)35(5)16-20/h6,8-9,13,15,17-18,20,24-26,33,41H,7,10-12,14,16H2,1-5H3,(H,34,38)/t20-,24-,25+,26+,31-,32+/m1/s1
• Clave InChI: InChIKey=YDOTUXAWKBPQJW-NSLWYYNWSA-N
• SMILES: CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12